Dafna Capital Management LLC Pharvaris N.V. Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$16.35 - $27.5 $565,955 - $951,912
-34,615 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$15.98 - $19.65 $33,637 - $41,363
-2,105 Reduced 5.73%
34,615 $628,000
Q4 2021

Feb 14, 2022
BUY
$13.28 - $18.0 $21,858 - $29,628
1,646 Added 4.69%
36,720 $528,000
Q3 2021

Nov 15, 2021
BUY
$13.14 - $20.97 $460,872 - $735,501
35,074 New
35,074 $622,000

Others Institutions Holding PHVS

# of Institutions
51
Shares Held
39.6M
Call Options Held
0
Put Options Held
0
View Full List

About Pharvaris N.V.

PHVS Quotes by TradingView
  • Ticker PHVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,766,000
  • Market Cap $625M
  • Description
  • Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...
More about PHVS
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email